MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
about
Serum or plasma ferritin concentration as an index of iron deficiency and overloadFerritin for the clinicianIatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyQuantitative Imaging Biomarkers of NAFLDThe Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment ResponseTreating iron overload in patients with non-transfusion-dependent thalassemiaMRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and PitfallsPregnancy in women with thalassemia: challenges and solutionsComparative in vitro study on magnetic iron oxide nanoparticles for MRI tracking of adipose tissue-derived progenitor cellsEffect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎).Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Advanced MRI methods for assessment of chronic liver diseaseEffect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging resultsLiver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T.Magnetic susceptibility as a B0 field strength independent MRI biomarker of liver iron overloadMeasurement of liver fat fraction and iron with MRI and MR spectroscopy techniques.Quantitative proton MR techniques for measuring fatAlgorithm for fast monoexponential fitting based on Auto-Regression on Linear Operations (ARLO) of data.Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases.Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T.Improved R2* measurements in myocardial iron overload.Overview of quantitative susceptibility mapping.3D Multiecho Dixon for the Evaluation of Hepatic Iron and Fat in a Clinical Setting.T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom.The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.Independent estimation of T*2 for water and fat for improved accuracy of fat quantificationQuantification of liver fat in the presence of iron overload.Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.Liver iron content determination by magnetic resonance imaging.Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan.Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopyIron overload in sickle cell disease.Estimation of liver T₂ in transfusion-related iron overload in patients with weighted least squares T₂ IDEAL.R2* imaging of transfusional iron burden at 3T and comparison with 1.5T.Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseasesNutritional deficiencies in iron overloaded patients with hemoglobinopathiesMRI detects myocardial iron in the human heart.Magnetic resonance imaging measurement of iron overload.Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.Quantitative assessment of iron in heart and liver phantoms using dual-energy computed tomography.
P2860
Q24186684-80585A54-0840-411F-A236-27365F69F136Q24642942-BEB1BFC0-4B65-423D-A34F-CC313956D5F4Q26752664-F73B325A-5534-4D18-B1D8-6302C089F9D9Q26768664-38894E08-D0E8-4242-8ED7-F6082FC6D4B1Q26773129-3FCE9B3E-72CE-4A97-B15F-AE154D53DD25Q27009463-28E9080D-B386-4724-B128-0000CF0B388FQ28072173-4E9032A9-75FD-405B-8AA3-FE16A7A13C82Q28080216-63DFA0DF-AA51-49E4-9D06-17B10747DC86Q28543135-3A2064A9-A82A-406E-8382-DA42AEF7E24FQ30303112-F26B545F-639C-4678-A028-CADE840ECB6CQ30417045-AD4BCC58-22CB-4F4A-83AE-F5482163BEEDQ30478601-B1233353-32E6-4E7E-ACDE-0EF68380106EQ30559328-ED474840-0D6A-4426-BC11-F80F7ECB0A57Q30616960-525F649E-B7DA-4A6D-B59A-964606CB5FF0Q30651689-F5E1285A-8C62-4C90-8BA5-259F223B7A46Q30667632-B5546BFA-4AB7-4EDB-8689-E5F76C03A18CQ30677112-D58D456D-B6CC-402D-8BE3-11D2AC0884E2Q30784862-1D166FA7-8377-4244-A1C1-BF367C8DD0C2Q30853786-6EAED195-8502-420A-A006-C414B33AE620Q30989859-97E77A3F-B242-4177-8427-FA3F554B4C12Q31023513-EFB0A3A6-E614-46E3-8147-FC011471BA78Q31115799-69294351-A779-40DD-B7BD-63CC46891A5AQ31164876-B788C077-D8FB-498A-B64B-A2C19A2080BEQ33512569-8AD891BF-12F5-4F68-A401-AEE4EA665044Q33526884-23FDD5D5-7704-4753-97AB-9944E077710AQ33550434-000DC9A2-1672-41E9-B0E4-D1C9D652A231Q33645229-47B8B7D0-313E-4302-AE02-F2633BC8CA10Q33647638-36268AE2-8455-42E8-8389-23F16BB6A90CQ33764777-A633AF40-EE85-40EC-845A-D1AA2288D1C5Q33783224-4BF59295-ECCC-440D-BDC3-8679F29CA568Q33797528-F00A8E49-75B0-46A3-A97E-8984051EC20CQ33861129-7C12B26D-DD3C-420A-8AB2-0D7E6E10342BQ33901119-04330C30-A0A4-45C2-8F82-C65974C97175Q33907529-C4151352-4F43-44D1-9EFE-4727FBECE87FQ33909042-7802F9F7-B8C2-4CE9-BCCE-6A0EF5B5C3A3Q33920978-11F5C08C-36A2-42B2-A7E0-24E1AE776071Q33921092-127E3B4D-014D-4B74-970D-CC84B1FBDB5FQ33944366-EB3A8322-F1CF-4F44-9260-E4EBBF4CC55EQ33958448-FFB0C0A2-ECB8-4F94-93CB-02A95A9A8FC6Q33962247-BC8FB406-8B9C-42F6-8E29-BD0F7D77A7B4
P2860
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
MRI R2 and R2* mapping accurat ...... d sickle cell disease patients
@ast
MRI R2 and R2* mapping accurat ...... d sickle cell disease patients
@en
type
label
MRI R2 and R2* mapping accurat ...... d sickle cell disease patients
@ast
MRI R2 and R2* mapping accurat ...... d sickle cell disease patients
@en
prefLabel
MRI R2 and R2* mapping accurat ...... d sickle cell disease patients
@ast
MRI R2 and R2* mapping accurat ...... d sickle cell disease patients
@en
P2093
P2860
P1433
P1476
MRI R2 and R2* mapping accurat ...... d sickle cell disease patients
@en
P2093
Cathleen Enriquez
J Michael Tyzka
John C Wood
Marvin D Nelson
Nilesh Ghugre
Susan Carson
P2860
P304
P356
10.1182/BLOOD-2004-10-3982
P407
P577
2005-04-28T00:00:00Z